Choice of Treatment for Patients With Non–small-cell Lung Cancer >5 cm Between Surgery Alone and Surgery Plus Adjuvant Radiotherapy

Choice of Treatment for Patients With Non–small-cell Lung Cancer >5 cm Between Surgery Alone and Surgery Plus Adjuvant Radiotherapy

Background: According to the lung cancer staging project, T2b (>5–7 cm) and T3 (>7 cm) non-small cell lung cancers (NSCLC) should be reclassified into T3 and T4 groups. The objective of this study was to evaluate the effect of surgery alone or surgery plus adjuvant radiation (SART) on...

Full description

Bibliographic Details
Main Authors: Boyan Wang, Yongjie Zhou, Min Jia, Zhiping Yan, Jiayan Chen, Xueguan Lu, Ruiyan Wu, Junmiao Wen
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Surgery
Subjects:
NSCLC
surgery
postoperative radiotherapy
node-negative
T-stage
Online Access:https://www.frontiersin.org/articles/10.3389/fsurg.2021.649802/full

Internet

https://www.frontiersin.org/articles/10.3389/fsurg.2021.649802/full

Similar Items